ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
18.00
+1.00 (5.88%)
May 30, 2025, 2:56 PM EDT

ZIVO Bioscience Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
0.120.160.03--0.02
Upgrade
Revenue Growth (YoY)
91.73%468.61%----
Upgrade
Cost of Revenue
0.090.110.02---
Upgrade
Gross Profit
0.040.050.01--0.02
Upgrade
Selling, General & Admin
10.7410.285.96.496.694.82
Upgrade
Research & Development
5.593.131.382.241.953.75
Upgrade
Operating Expenses
16.3313.417.278.738.658.58
Upgrade
Operating Income
-16.29-13.36-7.26-8.73-8.65-8.56
Upgrade
Interest Expense
-0.02-0.02-0.51--0.23-0.55
Upgrade
Other Non Operating Income (Expenses)
----0.01--
Upgrade
EBT Excluding Unusual Items
-16.32-13.38-7.78-8.75-8.88-9.11
Upgrade
Other Unusual Items
----0.12-
Upgrade
Pretax Income
-16.32-13.38-7.78-8.75-8.76-9.11
Upgrade
Net Income
-16.32-13.38-7.78-8.75-8.76-9.11
Upgrade
Net Income to Common
-16.32-13.38-7.78-8.75-8.76-9.11
Upgrade
Shares Outstanding (Basic)
332211
Upgrade
Shares Outstanding (Diluted)
332211
Upgrade
Shares Change (YoY)
72.21%87.41%7.65%23.47%50.26%46.96%
Upgrade
EPS (Basic)
-4.77-4.23-4.60-5.57-6.89-10.76
Upgrade
EPS (Diluted)
-4.77-4.23-4.60-5.57-6.89-10.76
Upgrade
Gross Margin
30.00%31.14%41.99%--100.00%
Upgrade
Operating Margin
-13411.40%-8498.85%-26267.68%---42778.38%
Upgrade
Profit Margin
-13430.07%-8513.44%-28127.25%---45528.64%
Upgrade
EBIT
-16.29-13.36-7.26-8.73-8.65-8.56
Upgrade
Revenue as Reported
0.120.160.03--0.02
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.